You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Insulin degrading enzyme / IDE antibody (ab25970)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab25970? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab25970 has been referenced in 8 publications.

  1. Kumar S et al. Phosphorylation of amyloid-ß peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes. J Biol Chem 287:8641-51 (2012). WB. PubMed: 22267728
  2. Glebov K et al. Functional relevance of a novel SlyX motif in non-conventional secretion of insulin-degrading enzyme. J Biol Chem 286:22711-5 (2011). WB. PubMed: 21576244
  3. Kilger E et al. BRI2 Protein Regulates {beta}-Amyloid Degradation by Increasing Levels of Secreted Insulin-degrading Enzyme (IDE). J Biol Chem 286:37446-57 (2011). WB; Human. PubMed: 21873424
  4. Tamboli IY et al. Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion. J Biol Chem 285:37405-14 (2010). WB; Mouse. PubMed: 20876579
  5. Hiltunen M et al. Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus. Neurobiol Dis 35:103-13 (2009). WB; Rat. PubMed: 19426802
  6. Vepsäläinen S et al. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology. Neurosci Lett 438:216-20 (2008). WB; Mouse. PubMed: 18455870
  7. Wang J et al. Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 28:6388-92 (2008). PubMed: 18562609
  8. Talvinen K et al. Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer. Br J Cancer 99:335-40 (2008). WB; Mouse. PubMed: 18594525

Publishing research using ab25970? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"